George Khelashvili
George Khelashvili
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
1,†,
Kevin Dorff
Kevin Dorff
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
2,†,
Jufang Shan
Jufang Shan
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
1,
Marta Camacho-Artacho
Marta Camacho-Artacho
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
3,
Lucy Skrabanek
Lucy Skrabanek
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
1,2,
Bas Vroling
Bas Vroling
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
4,
Michel Bouvier
Michel Bouvier
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
5,
Lakshmi A Devi
Lakshmi A Devi
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
6,
Susan R George
Susan R George
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
7,
Jonathan A Javitch
Jonathan A Javitch
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
8,
Martin J Lohse
Martin J Lohse
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
9,
Graeme Milligan
Graeme Milligan
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
10,
Richard R Neubig
Richard R Neubig
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
11,
Krzysztof Palczewski
Krzysztof Palczewski
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
12,
Marc Parmentier
Marc Parmentier
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
13,
Jean-Philippe Pin
Jean-Philippe Pin
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
14,
Gerrit Vriend
Gerrit Vriend
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
4,
Fabien Campagne
Fabien Campagne
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
1,2,
Marta Filizola
Marta Filizola
1 Department of Physiology & Biophysics, 2 Institute for Computational Biomedicine, Weill Medical College of Cornell University, 3 Department of Structural and Chemical Biology, Mount Sinai School of Medicine, New York, NY, USA, 4 Center for Molecular and Biomolecular Informatics, NCMLS, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands, 5 Department of Biochemistry and Groupe de Recherche Universitaire sur le Médicament, Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada, 6 Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY, USA, 7 Centre for Addiction and Mental Health and Department of Pharmacology, University of Toronto, Toronto, ON, Canada, 8 Center for Molecular Recognition, Department of Psychiatry and Department of Pharmacology, Columbia University College of Physicians and Surgeons, New York, NY, USA, 9 Institute of Pharmacology and Toxicology, University of Wurzburg, Wurzburg, Germany, 10 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life sciences, University of Glasgow, Glasgow, Scotland, UK, 11 Department of Pharmacology, University of Michigan, Ann Arbor, MI, 12 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Oh, USA, 13 Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Brussels, Belgium and 14 Institute of Functional Genomics, CNRS Unité Mixte de Recherche 5203, INSERM U661, Universités de Montpellier 1 et 2, Montpellier, France
3,*